Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL)

Austin J. StuckertTexas Children’s Cancer Center and Hematology Center, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX, USACorrespondence[email protected]

http://orcid.org/0000-0002-5938-7495

Eric S. SchaferTexas Children’s Cancer Center and Hematology Center, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX, USA

http://orcid.org/0000-0002-7063-512X

M. Brooke BernhardtTexas Children’s Cancer Center and Hematology Center, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX, USA

http://orcid.org/0000-0002-9612-3624

Patricia BaxterTexas Children’s Cancer Center and Hematology Center, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX, USA

http://orcid.org/0000-0003-3703-8742

Julienne BrackettTexas Children’s Cancer Center and Hematology Center, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX, USA

http://orcid.org/0000-0002-6782-1044

Click to increase image sizeClick to decrease image size

Acknowledgements

Austin J. Stuckert performed the research, designed the research study, analyzed the data, wrote the paper. Eric S. Schafer performed the research, designed the research study, analyzed the data, wrote the paper. M. Brooke Bernhardt performed the research, designed the research study, analyzed the data, wrote the paper. Patricia Baxter performed the research, designed the research study, analyzed the data, wrote the paper. Julienne Brackett performed the research, designed the research study, analyzed the data, wrote the paper.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL)

Information for

Open access

Opportunities

Help and information

Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL)

Acknowledgements

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature